AMIA joined Coalition for Health Funding’s letter, signed by over 500 health and research organizations, strongly opposing the Administration’s draft FY 2026 budget proposal for the Department of Health and Human Services (HHS), which includes a one-third cut to discretionary funding. The coalition warns such cuts would severely harm the […]
On April 23, 2025, AMIA joined over 100 organizations urging Congress to allocate at least $1.7 billion for the Advanced Research Projects Agency for Health (ARPA-H) in FY 2026, emphasizing the importance of maintaining its independence within the Department of Health and Human Services. ARPA-H, modeled after DARPA, has initiated […]
AMIA raised concerns about the evidence behind the HHS reorganization decisions and questions the exclusion of the Assistant Secretary for Technology Policy/Office of the National Coordinator of Health IT (ASTP). It highlights the importance of ASTP in securing patient data and supporting clinical care. AMIA also questioned the potential move […]
AMIA responded to the FDA's draft guidance on "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations." We commended the FDA for its comprehensive approach to ensuring the safe and effective use of AI-enabled devices in healthcare. The comment letter emphasized the importance of transparency, bias control, and […]